靶向5-HT2B受体信号可防止心肌梗死后边缘区扩展并改善微结构重塑
该研究探讨抑制5-HT2B受体信号对心肌梗死后瘢痕形成和心脏功能的影响。使用两种药理拮抗剂及诱导性基因消融技术,发现抑制5-HT2B可减少瘢痕厚度和边缘区面积,促进胶原纤维重分布,改善左室收缩功能并限制心肌肥厚。机制涉及减少成纤维细胞增殖、迁移和重塑能力,与Dnajb4表达和Src磷酸化改变相关。
要点
- 5-HT2B拮抗剂可减轻梗死后瘢痕厚度和边缘区面积,改善心脏结构和功能。
- 抑制5-HT2B促进胶原纤维变细且更各向异性,增强左室收缩力并降低纤维化组织硬度。
- 成纤维细胞或肌成纤维细胞特异性敲除5-HT2B均可改善心梗后结局。
核心结论
- 心脏成纤维细胞或活化肌成纤维细胞中的5-HT2B表达直接促进过度瘢痕形成,导致心梗后不良重塑和心功能受损。
研究设计与样本
- 使用两种5-HT2B药理拮抗剂探索抑制5-HT2B对心梗后结局的影响。
- 采用Tcf21MCM和PostnMCM驱动的诱导性5-HT2B消融分别评估心脏驻留成纤维细胞和肌成纤维细胞中5-HT2B的作用。
- 通过RNA测序和体外分析探索心脏成纤维细胞表型。
主要发现
- 5-HT2B拮抗通过促进瘢痕纤维化程度降低(表现为瘢痕厚度和边缘区面积减小)来保护心脏结构和功能。
- 5-HT2B拮抗导致胶原纤维重分布为更细且更各向异性的纤维,增强左室收缩力,同时纤维化组织硬度降低,限制未损伤心肌细胞的肥厚反应。
- Tcf21谱系驻留心脏成纤维细胞中消融5-HT2B可观察到与药理方法相似的改善。
- Postn谱系肌成纤维细胞中损伤后消融5-HT2B也改善心脏结局。
- RNA测序和体外分析证实通过改变Dnajb4表达和Src磷酸化降低成纤维细胞增殖、迁移和重塑能力。
临床怎么用
- 抑制5-HT2B信号可能成为限制心梗后过度瘢痕形成、改善微结构重塑和心脏功能的潜在策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Myocardial infarction (MI) induces an intense injury response that ultimately generates a collagen-dominated scar. Although required to prevent ventricular rupture, the fibrotic process is often sustained in a manner detrimental to optimal recovery. Cardiac myofibroblasts are the cells tasked with depositing and remodeling collagen and are a prime target to limit the fibrotic process after MI. Serotonin 2B receptor (5-HT2B) signaling has been shown to be harmful in a variety of cardiopulmonary pathologies and could play an important role in mediating scar formation after MI. METHODS: We used 2 pharmacological antagonists to explore the effect of 5-HT2B inhibition on outcomes after MI and characterized the histological and microstructural changes involved in tissue remodeling. Inducible 5-HT2B ablation driven by Tcf21MCM and PostnMCM was used to evaluate resident cardiac fibroblast- and myofibroblast-specific contributions of 5-HT2B, respectively. RNA sequencing was used to motivate subsequent in vitro analyses to explore cardiac fibroblast phenotype. RESULTS: 5-HT2B antagonism preserved cardiac structure and function by facilitating a less fibrotic scar, indicated by decreased scar thickness and decreased border zone area. 5-HT2B antagonism resulted in collagen fiber redistribution to thinner collagen fibers that were more anisotropic, enhancing left ventricular contractility, whereas fibrotic tissue stiffness was decreased, limiting the hypertrophic response of uninjured cardiomyocytes. Using a tamoxifen-inducible Cre, we ablated 5-HT2B from Tcf21-lineage resident cardiac fibroblasts and saw similar improvements to the pharmacological approach. Tamoxifen-inducible Cre-mediated ablation of 5-HT2B after onset of injury in Postn-lineage myofibroblasts also improved cardiac outcomes. RNA sequencing and subsequent in vitro analyses corroborate a decrease in fibroblast proliferation, migration, and remodeling capabilities through alterations in Dnajb4 expression and Src phosphorylation. CONCLUSIONS: Together, our findings illustrate that 5-HT2B expression in either cardiac fibroblasts or activated myofibroblasts directly contributes to excessive scar formation, resulting in adverse remodeling and impaired cardiac function after MI.
引用
- Snider JC, Riley LA, Mallory NT, et al. Targeting 5-HT2B Receptor Signaling Prevents Border Zone Expansion and Improves Microstructural Remodeling After Myocardial Infarction. Circulation. 2021. PMID: 33474971. doi:10.1161/CIRCULATIONAHA.120.051517
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。